API | sontuzumab

sontuzumab Report issue

Biologics mAb Experimental

AACT ChEMBL MeSH PubChem

Active Ingredient History

NOW

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules:

sontuzumab

epitumomab

epitumomab cituxetan

rg-1550

huhmfg1

More Chemistry

Pharmacology

Mechanisms of Action:
- Mucin-1 (Homo sapiens) ^UniProt
- Mucin-1 (Homo sapiens) ^UniProt
- Mucin-1 (Homo sapiens) ^UniProt
Multi-specific: No
Payload: cituxetan
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

as1402 | as 1402 | as-1402 | bth1704 | epitumomab | epitumomab cituxetan | huhmfg1 | huhmfg-1 | humanized human milk fat globule-1 monoclonal antibody | humanized igg1 monoclonal antibody | moab huhmfg1 | r1550 | r 1550 | r-1550 | r1550 cpd | rg-1550 | sontuzumab | therex

Organizations (6)

Research & Development (6)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (2)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (2)

Breast Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 1)

Overview

Highest Phase: Phase 2
# of Trials: 4
# of Trial Organizations: 6

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue